Hydra Biosciences, Inc., a biopharmaceutical company, developed novel drugs to treat pain, inflammation, renal, anxiety, pulmonary, and other diseases using novel ion channels as targets, specifically, members of the Transient Receptor Potential (TRP) family of ion channels. The company was founded in 2001 in Cambridge, Massachusetts.